The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small blood vessels, is the first drug approved for pediatric patients with aTTP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback